Methods of treating myelodysplastic syndrome with farnesyltransferase inhibitors
US-2017326133-A1 · Nov 16, 2017 · US
Kura Oncology Inc was listed as an assignee on 8 patent publications in 2017.
| Metric | Value |
|---|---|
| Company | Kura Oncology Inc |
| Year | 2017 |
| Patents | 8 |
Representative publications for Kura Oncology Inc in 2017.
US-2017326133-A1 · Nov 16, 2017 · US
US-2017304291-A1 · Oct 26, 2017 · US
US-2017247391-A1 · Aug 31, 2017 · US
US-2017226110-A1 · Aug 10, 2017 · US
US-9707221-B2 · Jul 18, 2017 · US
Most common classification codes for Kura Oncology Inc in 2017.
| CPC | Patents |
|---|---|
| A61K45/06 | 7 |
| A61P35/00 | 7 |
| A61K31/4709 | 5 |
| A61P35/04 | 5 |
| A61P43/00 | 5 |
Navigate to parent entity pages.